Tenecteplase for acute ischaemic stroke

European Stroke Organisation (ESO) guidelines on mobile stroke units for prehospital stroke management

(2022) Silke Walter et al.   European Stroke Journal

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

(2022) Christopher Elnan Kvistad et al.   LANCET NEUROLOGY

Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke

(2022) Aristeidis H. Katsanos et al.   JAMA Network Open

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

(2022) Bijoy K Menon et al.   LANCET

Stroke Thrombolysis With Tenecteplase to Reduce Emergency Department Spread of Coronavirus Disease 2019 and Shortages of Alteplase

(2020) Steven J. Warach et al.   JAMA Neurology

Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions

(2020) Aristeidis H. Katsanos et al.   STROKE

Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke

(2019) Christopher Elnan Kvistad et al.   STROKE

Safety and predictors of stroke mimics in The Norwegian Tenecteplase Stroke Trial (NOR-TEST)

(2018) Christopher Elnan Kvistad et al.   International Journal of Stroke

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

(2018) Bruce C.V. Campbell et al.   NEW ENGLAND JOURNAL OF MEDICINE